OBSEVA SA
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 2012-01-01
- Employees
- 15
- Market Cap
- -
- Website
- http://www.obseva.com
Clinical Trials
36
Active:25
Completed:8
Trial Phases
3 Phases
Phase 1:27
Phase 2:4
Phase 3:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (35 trials with phase data)• Click on a phase to view related trials
Phase 1
27 (77.1%)Phase 2
4 (11.4%)Phase 3
4 (11.4%)Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function
- First Posted Date
- 2019-05-23
- Last Posted Date
- 2020-03-05
- Lead Sponsor
- ObsEva SA
- Target Recruit Count
- 33
- Registration Number
- NCT03961932
- Locations
- 🇺🇸
Clinical Site, Saint Paul, Minnesota, United States
Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function
- First Posted Date
- 2019-05-23
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- ObsEva SA
- Target Recruit Count
- 24
- Registration Number
- NCT03962049
- Locations
- 🇺🇸
Clinical Site, Orlando, Florida, United States
Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2021-09-09
- Lead Sponsor
- ObsEva SA
- Target Recruit Count
- 820
- Registration Number
- NCT03758885
- Locations
- 🇧🇪
Site 1001, Brussels, Belgium
🇧🇪Site 1003, Brussels, Belgium
🇧🇪Site 1004, Brussels, Belgium
PoC Study of OBE022 in Threatened Preterm Labour
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2021-06-07
- Lead Sponsor
- ObsEva SA
- Target Recruit Count
- 115
- Registration Number
- NCT03369262
- Locations
- 🇨🇿
Gynekologicko-porodnická klinika Fakultní nemocnice Brno, Brno, Czechia
🇨🇿Gynekologicko-porodnická klinika 1. LF UK a VFN v Praze, Praha, Czechia
🇨🇿Ústav pro péči o matku a dítě, Praha, Czechia
Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI
- First Posted Date
- 2017-03-16
- Last Posted Date
- 2019-12-23
- Lead Sponsor
- ObsEva SA
- Target Recruit Count
- 810
- Registration Number
- NCT03081208
- Locations
- 🇧🇪
Investigator ID 1001, Brussels, Belgium
🇧🇪Investigator ID 1002, Brussels, Belgium
🇧🇪Investigator ID 1003, Brussels, Belgium
- Prev
- 1
- 2
- Next
News
No news found